Experimental and In Silico Modelling Analyses of the Gene Expression Pathway for Recombinant Antibody and By-Product Production in NS0 Cell Lines

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Mead, Emma J ^a   Chiverton, Lesley M ^a   Spurgeon, Sarah K ^a   Martin, Elaine B ^b   Montague, Gary A ^b   Smales, C Mark ^a   von der Haar, Tobias ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN G4 ANTIBODY; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CELL ENGINEERING; CELL LINE; COMPUTER MODEL; GENE EXPRESSION; MOUSE; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN FOLDING;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOTECHNOLOGY; BLOTTING, WESTERN; CELL LINE, TUMOR; CLUSTER ANALYSIS; DNA PRIMERS; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN G; MICE; MODELS, BIOLOGICAL; POLYMERASE CHAIN REACTION; PROTEIN FOLDING; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS;

EID: 84867340587     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047422     Document Type: Article

References (59)

1. Burnouf T, (2011) Recombinant plasma proteins. Vox Sang 100: 68-83.
2. Wurm FM, (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22: 1393-1398.
3. Lim Y, Wong NS, Lee YY, Ku SC, Wong DC, et al. (2010) Engineering mammalian cells in bioprocessing - current achievements and future perspectives. Biotechnol Appl Biochem 55: 175-189.
4. O'Callaghan PM, McLeod J, Pybus LP, Lovelady CS, Wilkinson SJ, et al. (2010) Cell line-specific control of recombinant monoclonal antibody production by CHO cells. Biotechnol Bioeng 106: 938-951.
5. Browne SM, Al-Rubeai M, (2007) Selection methods for high-producing mammalian cell lines. Trends Biotechnol 25: 425-432.
6. Sung YH, Song YJ, Lim SW, Chung JY, Lee GM, (2004) Effect of sodium butyrate on the production, heterogeneity and biological activity of human thrombopoietin by recombinant Chinese hamster ovary cells. J Biotechnol 112: 323-335.
7. Al-Fageeh MB, Marchant RJ, Carden MJ, Smales CM, (2006) The cold-shock response in cultured mammalian cells: harnessing the response for the improvement of recombinant protein production. Biotechnol Bioeng 93: 829-835.
8. Marchant RJ, Al-Fageeh MB, Underhill MF, Racher AJ, Smales CM, (2008) Metabolic rates, growth phase, and mRNA levels influence cell-specific antibody production levels from in vitro-cultured mammalian cells at sub-physiological temperatures. Mol Biotechnol 39: 69-77.
9. Kramer O, Klausing S, Noll T, (2010) Methods in mammalian cell line engineering: from random mutagenesis to sequence-specific approaches. Appl Microbiol Biotechnol 88: 425-436.
10. Figueroa B Jr, Ailor E, Osborne D, Hardwick JM, Reff M, et al. (2007) Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells. Biotechnol Bioeng 97: 877-892.
11. Figueroa B Jr, Chen S, Oyler GA, Hardwick JM, Betenbaugh MJ, (2004) Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions. Biotechnol Bioeng 85: 589-600.
12. Lim SF, Chuan KH, Liu S, Loh SO, Chung BY, et al. (2006) RNAi suppression of Bax and Bak enhances viability in fed-batch cultures of CHO cells. Metab Eng 8: 509-522.
13. Simpson NH, Milner AE, Al-Rubeai M, (1997) Prevention of hybridoma cell death by bcl-2 during suboptimal culture conditions. Biotechnol Bioeng 54: 1-16.
14. Bi JX, Shuttleworth J, Al-Rubeai M, (2004) Uncoupling of cell growth and proliferation results in enhancement of productivity in p21CIP1-arrested CHO cells. Biotechnol Bioeng 85: 741-749.
15. Fussenegger M, Schlatter S, Datwyler D, Mazur X, Bailey JE, (1998) Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol 16: 468-472.
16. Sunley K, Butler M, (2010) Strategies for the enhancement of recombinant protein production from mammalian cells by growth arrest. Biotechnol Adv 28: 385-394.
17. Borth N, Mattanovich D, Kunert R, Katinger H, (2005) Effect of increased expression of protein disulfide isomerase and heavy chain binding protein on antibody secretion in a recombinant CHO cell line. Biotechnol Prog 21: 106-111.
18. Dorner AJ, Kaufman RJ, (1994) The levels of endoplasmic reticulum proteins and ATP affect folding and secretion of selective proteins. Biologicals 22: 103-112.
19. Hayes NV, Smales CM, Klappa P, (2010) Protein disulfide isomerase does not control recombinant IgG4 productivity in mammalian cell lines. Biotechnol Bioeng 105: 770-779.
20. Josse L, Smales CM, Tuite MF, (2010) Transient expression of human TorsinA enhances secretion of two functionally distinct proteins in cultured Chinese hamster ovary (CHO) cells. Biotechnol Bioeng 105: 556-566.
21. Mohan C, Lee GM, (2010) Effect of inducible co-overexpression of protein disulfide isomerase and endoplasmic reticulum oxidoreductase on the specific antibody productivity of recombinant Chinese hamster ovary cells. Biotechnol Bioeng 107: 337-346.
22. Tigges M, Fussenegger M, (2006) Xbp1-based engineering of secretory capacity enhances the productivity of Chinese hamster ovary cells. Metab Eng 8: 264-272.
23. Underhill MF, Birch JR, Smales CM, Naylor LH, (2005) eIF2alpha phosphorylation, stress perception, and the shutdown of global protein synthesis in cultured CHO cells. Biotechnol Bioeng 89: 805-814.
24. Underhill MF, Coley C, Birch JR, Findlay A, Kallmeier R, et al. (2003) Engineering mRNA translation initiation to enhance transient gene expression in chinese hamster ovary cells. Biotechnol Prog 19: 121-129.
25. Underhill MF, Marchant RJ, Carden MJ, James DC, Smales CM, (2006) On the effect of transient expression of mutated eIF2alpha and eIF4E eukaryotic translation initiation factors on reporter gene expression in mammalian cells upon cold-shock. Mol Biotechnol 34: 141-149.
26. Peng RW, Guetg C, Tigges M, Fussenegger M, (2010) The vesicle-trafficking protein munc18b increases the secretory capacity of mammalian cells. Metab Eng 12: 18-25.
27. Ahmad N, Zhang J, Brown PJ, James DC, Birch JR, et al. (2006) On the statistical analysis of the GS-NS0 cell proteome: imputation, clustering and variability testing. Biochim Biophys Acta 1764: 1179-1187.
28. Alete DE, Racher AJ, Birch JR, Stansfield SH, James DC, et al. (2005) Proteomic analysis of enriched microsomal fractions from GS-NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities. Proteomics 5: 4689-4704.
29. Carlage T, Hincapie M, Zang L, Lyubarskaya Y, Madden H, et al. (2009) Proteomic profiling of a high-producing Chinese hamster ovary cell culture. Anal Chem 81: 7357-7362.
30. Dinnis DM, Stansfield SH, Schlatter S, Smales CM, Alete D, et al. (2006) Functional proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnol Bioeng 94: 830-841.
31. Doolan P, Meleady P, Barron N, Henry M, Gallagher R, et al. (2010) Microarray and proteomics expression profiling identifies several candidates, including the valosin-containing protein (VCP), involved in regulating high cellular growth rate in production CHO cell lines. Biotechnol Bioeng 106: 42-56.
32. Kantardjieff A, Jacob NM, Yee JC, Epstein E, Kok YJ, et al. (2010) Transcriptome and proteome analysis of Chinese hamster ovary cells under low temperature and butyrate treatment. J Biotechnol 145: 143-159.
33. Khoo SH, Falciani F, Al-Rubeai M, (2007) A genome-wide transcriptional analysis of producer and non-producer NS0 myeloma cell lines. Biotechnol Appl Biochem 47: 85-95.
34. Nissom PM, Sanny A, Kok YJ, Hiang YT, Chuah SH, et al. (2006) Transcriptome and proteome profiling to understanding the biology of high productivity CHO cells. Mol Biotechnol 34: 125-140.
35. Smales CM, Dinnis DM, Stansfield SH, Alete D, Sage EA, et al. (2004) Comparative proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. Biotechnol Bioeng 88: 474-488.
36. Stansfield SH, Allen EE, Dinnis DM, Racher AJ, Birch JR, et al. (2007) Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture. Biotechnol Bioeng 97: 410-424.
37. O'Callaghan PM, James DC, (2008) Systems biotechnology of mammalian cell factories. Brief Funct Genomic Proteomic 7: 95-110.
38. Ho Y, Varley J, Mantalaris A, (2006) Development and analysis of a mathematical model for antibody-producing GS-NS0 cells under normal and hyperosmotic culture conditions. Biotechnol Prog 22: 1560-1569.
39. Kontoravdi C, Asprey SP, Pistikopoulos EN, Mantalaris A, (2005) Application of global sensitivity analysis to determine goals for design of experiments: an example study on antibody-producing cell cultures. Biotechnol Prog 21: 1128-1135.
40. Mead EJ, Chiverton LM, Smales CM, von der Haar T, (2009) Identification of the limitations on recombinant gene expression in CHO cell lines with varying luciferase production rates. Biotechnol Bioeng 102: 1593-1602.
41. Beck A, Wurch T, Bailly C, Corvaia N, (2010) Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 10: 345-352.
42. Baumal R, Potter M, Scharff MD, (1971) Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. 3. Assembly of the three subclasses of IgG. J Exp Med 134: 1316-1334.
43. Whiteley EM, Hsu TA, Betenbaugh MJ, (1997) Modeling assembly, aggregation, and chaperoning of immunoglobulin G production in insect cells. Biotechnol Bioeng 56: 106-116.
44. Abe Y, Gor J, Bracewell DG, Perkins SJ, Dalby PA, (2010) Masking of the Fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy. Biochem J 432: 101-111.
45. Peters SJ, Smales CM, Henry AJ, Stephens PE, West S, et al. (2012) Engineering an improved IgG4 molecule with reduced disulphide bond heterogeneity and increased Fab domain thermal stability. J Biol Chem 287: 24525-24533.
46. McLeod J, O'Callaghan PM, Pybus LP, Wilkinson SJ, Root T, et al. (2011) An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer. Biotechnol Bioeng. 108: 2193-2204.
47. Labrijn AF, Buijsse AO, van den Bremer ET, Verwilligen AY, Bleeker WK, et al. (2009) Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo. Nat Biotechnol 27: 767-771.
48. Forrer K, Hammer S, Helk B, (2004) Chip-based gel electrophoresis method for the quantification of half-antibody species in IgG4 and their by- and degradation products. Anal Biochem 334: 81-88.
49. von der Haar T, McCarthy JE, (2002) Intracellular translation initiation factor levels in Saccharomyces cerevisiae and their role in cap-complex function. Mol Microbiol 46: 531-544.
50. Sears DW, Mohrer J, Beychok S, (1975) A kinetic study in vitro of the reoxidation of interchain disulfide bonds in a human immunoglobulin IgGLk. Correlation between sulfhydryl disappearance and intermediates in covalent assembly of H2L2. Proc Natl Acad Sci U S A 72: 353-357.
51. Golub GH, Van Loan CF (1996) Matrix computations. Baltimore: Johns Hopkins University Press.
52. Kalman RE, (1960) On the general theory of control systems. Proceedings of the First IFAC Congress on Automatic Control 1: 481-492.
53. Florin L, Pegel A, Becker E, Hausser A, Olayioye MA, et al. (2009) Heterologous expression of the lipid transfer protein CERT increases therapeutic protein productivity of mammalian cells. J Biotechnol 141: 84-90.
54. Peng RW, Abellan E, Fussenegger M, (2011) Differential effect of exocytic SNAREs on the production of recombinant proteins in mammalian cells. Biotechnol Bioeng 108: 611-620.
55. Peng RW, Fussenegger M, (2009) Molecular engineering of exocytic vesicle traffic enhances the productivity of Chinese hamster ovary cells. Biotechnol Bioeng 102: 1170-1181.
56. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
57. Towbin H, Staehelin T, Gordon J, (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76: 4350-4354.
58. Renard JM, Spagnoli R, Mazier C, Salles MF, Mandine E, (1988) Evidence that monoclonal antibody production kinetics is related to the integral of the viable cells curve in batch systems. Biotechnology Letters 10: 91-96.
59. Porter AJ, Racher AJ, Preziosi R, Dickson AJ, (2010) Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: improving the efficiency of cell line generation. Biotechnol Prog 26: 1455-1464.